V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004506 | 310001977 | 1.8 | null | Disease modification (D) | 2016-10-08 | 2016-10-08 | Cisplatin + Docetaxel +Fluorouracil | null | null | 310019981 | EOX |
| 310004507 | 310001977 | 1.61 | 66 | Palliative (P) | 2017-01-12 | 2016-08-04 | CISPLATIN + FLUOROURACIL | N | N | 310019981 | LIPOSOMAL DOXORUBICIN |
| 310004508 | 310001978 | 1.6 | 66 | Neo-adjuvant (N) | 2017-01-20 | 2017-02-13 | GEM-P | 2 | N | 310019990 | MITOMYCIN INTRAVESICULAR |
| 310004509 | 310001979 | 1.57 | 91.5 | Palliative (P) | null | 2018-04-04 | ICON8 TRIAL | N | N | 310019991 | CISPLATIN + FLUOROURACIL |
| 310004510 | 310001980 | 1.73 | null | Disease modification (D) | 2016-11-21 | 2016-11-30 | Hydroxycarbamide | 02 | N | 310019993 | HYDROXYCARBAMIDE |
| 310004511 | 310001981 | 1.7 | 104.8 | Palliative (P) | null | 2015-05-23 | Bexarotene | 02 | N | 310019995 | GEMCITABINE + PACLITAXEL |
| 310004512 | 310001982 | 1.57 | 82.4 | Adjuvant (A) | 2017-05-12 | 2017-06-01 | Cisplatin + Etoposide (3 day) | 02 | N | 310019996 | BCG |
| 310004513 | 310001983 | 1.71 | 100 | null | 2017-07-23 | 2017-07-24 | ECX | null | Y | 310019997 | PACLITAXEL |
| 310004514 | 310001983 | 0 | 61.7 | Adjuvant (A) | 2017-08-26 | 2017-08-26 | CHOEP - 14 days | 2 | N | 310019997 | MITOMYCIN INTRAVESICULAR |
| 310004515 | 310001984 | 1.66 | null | Adjuvant (A) | 2014-09-22 | 2014-09-24 | Hydroxycarbamide | null | null | 310020000 | CISPLATIN + ETOPOSIDE |
| 310004516 | 310001985 | 1.77 | 58.4 | Curative (C) | 2017-08-12 | 2017-08-25 | CISPLATIN + FLUOROURACIL | 02 | N | 310020002 | HYDROXYCARBAMIDE |
| 310004517 | 310001986 | 1.56 | -1 | Disease modification (D) | 2015-07-04 | 2015-07-08 | Cisplatin + Docetaxel +Fluorouracil | null | null | 310020003 | RITUXIMAB |
| 310004518 | 310001986 | 1.52 | 76.9 | Palliative (P) | 2016-09-17 | 2016-10-04 | EOX | N | N | 310020003 | DACARBAZINE |
| 310004519 | 310001987 | 1.75 | 104.8 | Palliative (P) | 2018-06-23 | 2018-07-02 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310020005 | PACLITAXEL |
| 310004520 | 310001987 | 1.61 | null | Curative (C) | 2017-01-17 | 2017-01-22 | EOX | N | N | 310020005 | LIPOSOMAL DOXORUBICIN |
| 310004521 | 310009189 | 1.55 | 56.4 | null | 2015-01-26 | 2015-01-27 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020007 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004522 | 310009189 | 1.7 | 79 | Palliative (P) | 2014-12-31 | 2015-01-03 | CAPECITABINE + OXALIPLATIN | N | N | 310020007 | CISPLATIN + ETOPOSIDE |
| 310004523 | 310001988 | 1.89 | 89 | null | 2017-02-03 | 2017-02-08 | EOX | N | N | 310020009 | IMATINIB |
| 310004524 | 310001989 | 1.7 | 70 | Disease modification (D) | 2017-05-13 | 2017-05-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 310020014 | EOX |
| 310004525 | 310001990 | 1.62 | 77.7 | 4 | 2013-06-28 | 2013-07-20 | Capecitabine + Cisplatin | 02 | N | 310020015 | OXALIPLATIN + MDG |
| 310004526 | 310001990 | 1.64 | 75 | Neo-adjuvant (N) | 2014-06-21 | 2014-07-10 | Gemcitabine weekly | null | null | 310020015 | GEMCITABINE + PACLITAXEL |
| 310004527 | 310001990 | 1.73 | 75.7 | Palliative (P) | 2017-01-20 | 2017-02-10 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310020015 | IPILIMUMAB + NIVOLUMAB |
| 310004528 | 310001990 | 0 | null | Palliative (P) | null | 2014-01-17 | Mitomycin Intravesical | N | N | 310020015 | CAPECITABINE |
| 310004529 | 310001991 | 1.82 | 6.5 | Palliative (P) | 2014-10-30 | 2014-11-27 | Gemcitabine weekly | 2 | N | 310020021 | GEMCITABINE |
| 310004530 | 310001992 | 1.7 | 69.2 | Palliative (P) | 2017-07-17 | 2017-07-19 | ECX | N | N | 310020022 | ECX |
| 310004531 | 310001993 | 1.63 | 70 | Curative (C) | 2014-06-03 | 2014-06-14 | Mitomycin Intravesical | N | null | 310020025 | CAPECITABINE + OXALIPLATIN |
| 310004532 | 310006845 | null | null | Palliative (P) | 2014-04-09 | 2014-05-01 | EOX | N | N | 310020028 | CAPECITABINE + CISPLATIN |
| 310004533 | 310009191 | 1.7 | 0 | Curative (C) | null | 2013-03-13 | ICON8 TRIAL | N | N | 310020029 | LIPOSOMAL DOXORUBICIN |
| 310004534 | 310001994 | 1.66 | 89.5 | Curative (C) | 2017-07-07 | 2017-07-15 | CHOEP - 14 days | 02 | null | 310020031 | CHOEP |
| 310004535 | 310001995 | 1.61 | 83.1 | Palliative (P) | 2016-03-27 | 2016-04-10 | ICON8 TRIAL | N | N | 310020032 | HYDROXYCARBAMIDE |
| 310004536 | 310001996 | 1.91 | 70.6 | null | null | 2014-09-09 | FLUOROURACIL + OXALIPLATIN | null | null | 310020040 | DACARBAZINE |
| 310004538 | 310001998 | null | 66 | Curative (C) | 2018-05-21 | 2018-06-03 | EOX | N | N | 310020043 | BEXAROTENE |
| 310004539 | 310006846 | 1.77 | 66.1 | Palliative (P) | 2013-06-17 | 2013-06-23 | Vemurafenib | 02 | null | 310020045 | ICON TRIAL |
| 310004540 | 310009192 | 1.59 | 62.4 | Palliative (P) | 2014-05-17 | 2014-05-18 | ECX | N | N | 310020046 | PACLITAXEL |
| 310004541 | 310001999 | 1.73 | 82.4 | Neo-adjuvant (N) | null | 2015-04-09 | ECX | 01 | N | 310020047 | ECX |
| 310004542 | 310002000 | 1.52 | 68 | Palliative (P) | 2018-11-25 | 2018-11-26 | GEM-P | N | N | 310020049 | LIPOSOMAL DOXORUBICIN |
| 310004543 | 310002000 | 1.66 | 91.5 | Palliative (P) | 2016-08-10 | 2016-08-24 | Capecitabine + Cisplatin | N | null | 310020049 | CAPECITABINE + OXALIPLATIN |
| 310004544 | 310002000 | null | null | Curative (C) | 2016-04-01 | 2016-04-02 | CHOEP - 21 days | N | null | 310020049 | CHOEP |
| 310004545 | 310002001 | 1.59 | null | Curative (C) | 2015-04-21 | 2015-05-20 | CHOEP - 21 days | 2 | N | 310020056 | CHOEP |
| 310004546 | 310002001 | 1.7 | 59.5 | Curative (C) | 2016-08-13 | 2016-08-14 | NB HRNBL-1 Isotretinoin | N | N | 310020056 | NOT MATCHED |
| 310004547 | 310002001 | 1.69 | 62.2 | Curative (C) | 2014-04-25 | 2014-04-25 | EOX | N | N | 310020056 | MITOMYCIN INTRAVESICULAR |
| 310004548 | 310002001 | 1.84 | 0 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-23 | Dacarbazine | N | N | 310020056 | HYDROXYCARBAMIDE |
| 310004549 | 310002001 | 1.61 | 104 | Adjuvant (A) | 2016-02-21 | 2016-03-30 | GEMCITABINE | Y | N | 310020056 | GEMCITABINE |
| 310004550 | 310002001 | 1.69 | 16 | Disease modification (D) | 2014-09-03 | 2017-11-19 | Imatinib 400mg | N | N | 310020056 | EOX |
| 310004551 | 310002001 | 1.8 | 85.9 | Palliative (P) | 2013-07-27 | 2013-07-31 | IPILIMUMAB + NIVOLUMAB | N | N | 310020056 | IPILIMUMAB + NIVOLUMAB |
| 310004552 | 310011800 | 1.74 | 71.9 | Palliative (P) | 2017-04-06 | 2017-04-22 | IPILIMUMAB + NIVOLUMAB | N | N | 310020066 | IPILIMUMAB + NIVOLUMAB |
| 310004555 | 310002003 | null | null | Palliative (P) | 2015-03-15 | 2015-03-18 | IPILIMUMAB + NIVOLUMAB | Y | N | 310020069 | IPILIMUMAB + NIVOLUMAB |
| 310004556 | 310002003 | 0 | 58.6 | Disease modification (D) | 2013-11-09 | 2013-11-09 | Dacarbazine | N | N | 310020069 | CISPLATIN + FLUOROURACIL |
| 310004557 | 310002003 | 1.77 | 55.4 | Neo-adjuvant (N) | 2014-11-17 | 2014-11-24 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020069 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004558 | 310002004 | 1.72 | null | null | null | 2014-09-11 | Bexarotene | N | N | 310020072 | VEMURAFENIB |